Page last updated: 2024-09-03

umifenovir and Respiratory Syndrome, Acute, Severe

umifenovir has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, Y; Zhu, LQ1

Reviews

1 review(s) available for umifenovir and Respiratory Syndrome, Acute, Severe

ArticleYear
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019.
    World journal of pediatrics : WJP, 2020, Volume: 16, Issue:3

    Topics: Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; China; Chloroquine; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Male; Pandemics; Pharmaceutical Services; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Treatment Outcome

2020